Long Term Incentive Plan Award
LTIP award of 282,353 shares granted to CFO Helen Jones with three-year vesting based on Adjusted EBITDA per share growth.
Select text to share a quote on X · sign in to keep highlights & notes in your EKF notes
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that the Board, following the recommendation of the remuneration committee and after consulting its advisers, has today made the following award (the "Award") to Helen Jones (Chief Financial Officer) under the Company's established LTIP that was adopted on 9 September 2025:
| Individual | Position | Type of Award | Number of ordinary shares subject to LTIP award |
|---|---|---|---|
| Helen Jones | Chief Financial Officer | LTIP award - nominal cost option | 282,353 |
The Award has a performance period from the grant date to the third anniversary of the grant date and are subject to the following performance criteria.
The Award shall vest on a sliding scale depending on the total percentage growth of Adjusted EBITDA per share over the Performance Period, as follows:
| (i) | Growth of 25% or higher: 100% of the Award vests. |
| (ii) | Between 10% and 25% growth: Vesting shall occur on a straight-line basis between 25% and 100%. |
| (iii) | 10% growth: 25% of the Award vests; or |
| (iv) | Below 10% growth: 0% of the Award vests. |
Jenny Winter, Chair of the Remuneration committee, commented:
"It is important that our newly appointed CFO, Helen, is rewarded such that her performance indicators align with shareholder value creation. I am satisfied that these incentivisation arrangements achieve that objective."
| EKF Diagnostics Holdings plc | www.ekfdiagnostics.com | |
| Julian Baines, Executive Chair | Via Walbrook PR | |
| Gavin Jones, Chief Executive Officer | ||
| Singer Capital Markets (Nominated Adviser & Broker) | Tel: +44 (0)20 7496 3000 | |
| Phil Davies / Patrick Weaver | ||
| Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com | |
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
| a) | Name | Helen Jones |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Financial Officer |
| b) | Initial notification /Amendment | Initial Notification |
| a) | Name | EKF Diagnostics Holdings plc |
| b) | LEI | 213800DXTF3EAUK1AR05 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 1 pence each |
| Identification code | GB0031509804 | |
| b) | Nature of the transaction | Grant of options over ordinary shares pursuant to the Company's LTIP |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| 1p | 282,353 | |
| d) | Aggregated information | |
| - Aggregated volume | n/a | |
| - Price | ||
| e) | Date of the transaction | 20 May 2026 |
| f) | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.